U.S. Markets close in 5 hrs 14 mins

Global Transdermal Drug Delivery Industry

NEW YORK, July 29, 2019 /PRNewswire/ -- Transdermal Drug Delivery market worldwide is projected to grow by US$3 Billion, guided by a compounded growth of 7.

Download the full report: https://www.reportbuyer.com/product/5799828/?utm_source=PRN

5%. Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides the latest scoop on all major market segments. Cardiovascular, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2 Billion by the year 2025, Cardiovascular will bring in healthy gains adding significant momentum to global growth.

- While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 9.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$225.5 Million to the region's size and clout in the next 5 to 6 yearsOver US$374.4 Million worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Cardiovascular will reach a market size of US$139.9 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.1% over the next couple of years and add approximately US$504.3 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Antares Pharma, Inc. (USA); Bayer AG (Germany); Durect Corporation (USA); Iontera, Inc. (USA); Janssen Pharmaceuticals, Inc. (USA); Nitto Denko Corporation (Japan); Novartis AG (Switzerland); Pantec Biosolutions AG (Liechtenstein); Tesa Labtec GmbH (Germany); Teva Pharmaceutical Industries Ltd. (Israel)

Download the full report: https://www.reportbuyer.com/product/5799828/?utm_source=PRN

TRANSDERMAL DRUG DELIVERY MARKET ANALYSIS, TRENDS, AND FORECASTS, JULY 2019
CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares
Transcritical CO2 Systems Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: Transdermal Drug Delivery Global Market Estimates and
Forecasts in $ Million by Region/Country: 2018-2025
Table 2: Transdermal Drug Delivery Global Retrospective Market
Scenario in $ Million by Region/Country: 2009-2017
Table 3: Transdermal Drug Delivery Market Share Shift across
Key Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Cardiovascular (End-Use) Global Opportunity Assessment
in $ Million by Region/Country: 2018-2025
Table 5: Cardiovascular (End-Use) Historic Sales Analysis in $
Million by Region/Country: 2009-2017
Table 6: Cardiovascular (End-Use) Percentage Share Breakdown of
Global Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: CNS (End-Use) Worldwide Sales in $ Million by
Region/Country: 2018-2025
Table 8: CNS (End-Use) Historic Demand Patterns in $ Million by
Region/Country: 2009-2017
Table 9: CNS (End-Use) Market Share Shift across Key
Geographies: 2009 VS 2019 VS 2025
Table 10: Dermatology (End-Use) Demand Potential Worldwide in $
Million by Region/Country: 2018-2025
Table 11: Dermatology (End-Use) Historic Sales Analysis in $
Million by Region/Country: 2009-2017
Table 12: Dermatology (End-Use) Share Breakdown Review by
Region/Country: 2009 VS 2019 VS 2025
Table 13: Other End-Uses (End-Use) Worldwide Latent Demand
Forecasts in $ Million by Region/Country: 2018-2025
Table 14: Other End-Uses (End-Use) Global Historic Analysis in
$ Million by Region/Country: 2009-2017
Table 15: Other End-Uses (End-Use) Distribution of Global Sales
by Region/Country: 2009 VS 2019 VS 2025
Table 16: Pain Management (End-Use) Global Market Estimates &
Forecasts in $ Million by Region/Country: 2018-2025
Table 17: Pain Management (End-Use) Retrospective Demand
Analysis in $ Million by Region/Country: 2009-2017
Table 18: Pain Management (End-Use) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES MARKET Facts & Figures
US Transcritical CO2 Systems Market Share (in %) by Company:
2019 & 2025
Table 19: United States Transdermal Drug Delivery Latent Demand
Forecasts in $ Million by End-Use: 2018 to 2025
Table 20: Transdermal Drug Delivery Historic Demand Patterns in
the United States by End-Use in $ Million for 2009-2017
Table 21: Transdermal Drug Delivery Market Share Breakdown in
the United States by End-Use: 2009 VS 2019 VS 2025
CANADA
Table 22: Canadian Transdermal Drug Delivery Market
Quantitative Demand Analysis in $ Million by End-Use: 2018 to
2025
Table 23: Transdermal Drug Delivery Market in Canada:
Summarization of Historic Demand Patterns in $ Million by
End-Use for 2009-2017
Table 24: Canadian Transdermal Drug Delivery Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
JAPAN
Table 25: Japanese Demand Estimates and Forecasts for
Transdermal Drug Delivery in $ Million by End-Use: 2018 to 2025
Table 26: Japanese Transdermal Drug Delivery Market in $
Million by End-Use: 2009-2017
Table 27: Transdermal Drug Delivery Market Share Shift in Japan
by End-Use: 2009 VS 2019 VS 2025
CHINA
Table 28: Chinese Demand for Transdermal Drug Delivery in $
Million by End-Use: 2018 to 2025
Table 29: Transdermal Drug Delivery Market Review in China in $
Million by End-Use: 2009-2017
Table 30: Chinese Transdermal Drug Delivery Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
EUROPE MARKET Facts & Figures
European Transcritical CO2 Systems Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 31: European Transdermal Drug Delivery Market Demand
Scenario in $ Million by Region/Country: 2018-2025
Table 32: Transdermal Drug Delivery Market in Europe: A
Historic Market Perspective in $ Million by Region/Country for
the Period 2009-2017
Table 33: European Transdermal Drug Delivery Market Share Shift
by Region/Country: 2009 VS 2019 VS 2025
Table 34: European Transdermal Drug Delivery Addressable Market
Opportunity in $ Million by End-Use: 2018-2025
Table 35: Transdermal Drug Delivery Market in Europe:
Summarization of Historic Demand in $ Million by End-Use for
the Period 2009-2017
Table 36: European Transdermal Drug Delivery Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
FRANCE
Table 37: Transdermal Drug Delivery Quantitative Demand
Analysis in France in $ Million by End-Use: 2018-2025
Table 38: French Transdermal Drug Delivery Historic Market
Review in $ Million by End-Use: 2009-2017
Table 39: French Transdermal Drug Delivery Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
GERMANY
Table 40: Transdermal Drug Delivery Market in Germany: Annual
Sales Estimates and Forecasts in $ Million by End-Use for the
Period 2018-2025
Table 41: German Transdermal Drug Delivery Market in Retrospect
in $ Million by End-Use: 2009-2017
Table 42: Transdermal Drug Delivery Market Share Distribution
in Germany by End-Use: 2009 VS 2019 VS 2025
ITALY
Table 43: Italian Demand for Transdermal Drug Delivery in $
Million by End-Use: 2018 to 2025
Table 44: Transdermal Drug Delivery Market Review in Italy in $
Million by End-Use: 2009-2017
Table 45: Italian Transdermal Drug Delivery Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
UNITED KINGDOM
Table 46: United Kingdom Demand Estimates and Forecasts for
Transdermal Drug Delivery in $ Million by End-Use: 2018 to 2025
Table 47: United Kingdom Transdermal Drug Delivery Market in $
Million by End-Use: 2009-2017
Table 48: Transdermal Drug Delivery Market Share Shift in the
United Kingdom by End-Use: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 49: Rest of Europe Transdermal Drug Delivery Addressable MARKET Opportunity in $ Million by End-Use: 2018-2025
Table 50: Transdermal Drug Delivery Market in Rest of Europe:
Summarization of Historic Demand in $ Million by End-Use for
the Period 2009-2017
Table 51: Rest of Europe Transdermal Drug Delivery Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 52: Transdermal Drug Delivery Quantitative Demand
Analysis in Asia-Pacific in $ Million by End-Use: 2018-2025
Table 53: Asia-Pacific Transdermal Drug Delivery Historic MARKET Review in $ Million by End-Use: 2009-2017
Table 54: Asia-Pacific Transdermal Drug Delivery Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
REST OF WORLD
Table 55: Rest of World Transdermal Drug Delivery Market
Quantitative Demand Analysis in $ Million by End-Use: 2018 to
2025
Table 56: Transdermal Drug Delivery Market in Rest of World:
Summarization of Historic Demand Patterns in $ Million by
End-Use for 2009-2017
Table 57: Rest of World Transdermal Drug Delivery Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025

IV. COMPETITION

ADVANSOR A/S
BITZER KüHLMASCHINENBAU GMBH
BALTIMORE AIRCOIL COMPANY
CARNOT REFRIGERATION
CARRIER COMMERCIAL REFRIGERATION EUROPE
CLARIANT AG
DANFOSS GMBH
DOWDUPONT
EMERSON CLIMATE TECHNOLOGIES
GREEN & COOL
HALLIBURTON
HENRY TECHNOLOGIES
KEMIRA OYJ
LMP SYSTEMS INC.
MAYEKAWA MFG.
NALCO AN ECLOAB COMPANY
PARKER HANNIFIN CORPORATION
SCM FRIGO S.P.A
SCHLUMBERGER
SHECCO SPRL
STEPAN COMPANY
THE LUBRIZOL CORPORATION

V. CURATED RESEARCH
Download the full report: https://www.reportbuyer.com/product/5799828/?utm_source=PRN

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

Cision

View original content:http://www.prnewswire.com/news-releases/global-transdermal-drug-delivery-industry-300892494.html